Listed by the USPTO as BRAUN, MADELINE E
Tech Center 1600 • Art Units: 1624 1626 1629
This examiner grants 68% of resolved cases
USPTO examiner BRAUN, MADELINE E is assigned to Tech Center 1600 and Art Unit 1624. The record shows 154 resolved cases, a 68.2% allowance rate, a 25.4% interview lift, and a median of 1346 days to allowance. The figures support a positive but deliberate interview strategy.
Leading company matters include Hoffmann-La Roche Inc., University of Massachusetts, and Dana-Farber Cancer Institute Inc. Leading firms include FOLEY HOAG, LLP (General), THOMAS | HORSTEMEYER, LLP, and VIKSNINS HARRIS PADYS MALEN LLP. Practitioners should combine interview preparation with planning for the extended stated timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18833591 | COMPOSITIONS OF AUTOPHAGY MODULATING AGENTS AND USES THEREOF | Non-Final OA | Washington University |
| 18861291 | PENEM ANTIBACTERIALS AGAINST MYCOBACTERIAL PATHOGENS AND D,D- AND L,D TRANSPEPTIDASES | Non-Final OA | The Johns Hopkins University |
| 18710037 | METHOD OF TREATING CANCER ASSOCIATED WITH RAS MUTATION | Non-Final OA | The United States Government as Represented by The Department of Veterans Affairs |
| 18126273 | METHOD FOR TREATING DEMYELINATING CONDITIONS | Final Rejection | GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD. |
| 18713496 | SMALL MOLECULE INHIBITORS OF KRAS MUTATED PROTEINS | Non-Final OA | TAIHO PHARMACEUTICAL CO., LTD. |
| 18678103 | HETEROARYL SUBSTITUTED BETA-HYDROXYETHYLAMINES FOR USE IN TREATING HYPERGLYCAEMIA | Non-Final OA | ATROGI AB |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy68.2% of resolved applications examined by Madeline E Braun were allowed (154 resolved cases), compared with 54.4% across Art Unit 1624 over the last five years.
This examiner's interview lift is +25.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Madeline E Braun took 1,346 days on average from filing to allowance.
Madeline E Braun examines applications in Art Unit 1624 in Tech Center 1600 (Biotechnology & Pharmaceuticals).